Nordic Nanovector - Private placement successfully completed
Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia Oslo, Norway, 25 January 2019 Reference is made to the stock exchange release from Nordic Nanovector ASA (OSE: NANO) ("Nordic Nanovector" or the "Company"), a biopharmaceutical company dedicated to extending and improving the lives of patients with haematological cancers through the development and commercialisation of innovative targeted therapeutics, published on 24 January 2019 regarding the contemplated private placement of new shares in the Company.